BioSpace News Archive

Atara Biotherapeutics, Inc. reported the grant of inducement awards to Kristin Yarema, its Chief Commercial Officer.

The Company has been Granted European Union Trademark Number: 018138334 NEW YORK, NY, Feb. 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has received a notice of allowance from the European Unio

The Chief Public Health Officer, Dr. Theresa Tam, and the Deputy Chief Public Health Officer, Dr. Howard Njoo, will hold a media availability to provide an update on the novel coronavirus..

Montis Biosciences announces its launch with €8,4 million in seed financing from an international investor syndicate to investigate interactions between perivascular macrophages and tumor vasculature.

Philanthropic Tej Kohli Foundation will establish a new incubator to back scientific projects and commercial ventures that are targeting new solutions.

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that, due to strong demand, it has increased its previously announced non-brokered private placement of units (the “Units”), and has issued an aggregate of 18,304,939 Units at the price of CDN$0.085 per Unit, raising gross proceeds of CDN$1,555,919.82 (the “Offering”).

Ampio Pharmaceuticals, Inc. announced updates regarding the continued progress of its Phase III AP-013 clinical trial and receipt of its annual audit opinion.

Harbour BioMed (HBM) today announced completion of a Phase 1 study of HBM9161, a fully human anti-FcRn monoclonal antibody, to evaluate its safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Chinese subjects

HMS Holdings Corp. (Nasdaq: HMSY) today announced financial results for the fourth quarter and full year ended December 31, 2019.

EPIC Insurance Brokers and Consultants, a retail property, casualty insurance brokerage and employee benefits consultant, announced today that Trent Sullivan has joined the firm as a Producer in the firm’s Edgewood Healthcare Advisors’ Practice.